GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Talphera Inc (FRA:R5XA) » Definitions » Accounts Payable

Talphera (FRA:R5XA) Accounts Payable : €1.17 Mil (As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Talphera Accounts Payable?

Talphera's Accounts Payable for the quarter that ended in Mar. 2024 was €1.17 Mil.

Talphera's quarterly Accounts Payable increased from Sep. 2023 (€0.96 Mil) to Dec. 2023 (€1.23 Mil) but then declined from Dec. 2023 (€1.23 Mil) to Mar. 2024 (€1.17 Mil).

Talphera's annual Accounts Payable declined from Dec. 2021 (€1.88 Mil) to Dec. 2022 (€1.19 Mil) but then increased from Dec. 2022 (€1.19 Mil) to Dec. 2023 (€1.23 Mil).


Talphera Accounts Payable Historical Data

The historical data trend for Talphera's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Talphera Accounts Payable Chart

Talphera Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.55 2.25 1.88 1.19 1.23

Talphera Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.31 1.12 0.96 1.23 1.17

Talphera Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Talphera Accounts Payable Related Terms

Thank you for viewing the detailed overview of Talphera's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Talphera (FRA:R5XA) Business Description

Traded in Other Exchanges
Address
25821 Industrial Boulevard, Suite 400, Hayward, CA, USA, 94545
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Its product portfolio includes Niyad that is a lyophilized formulation of nafamostat. It is also developing two pre-filled syringes, a pre-filled ephedrine syringe, and PFS-02, a pre-filled phenylephrine syringe.

Talphera (FRA:R5XA) Headlines

No Headlines